JP2024507905A - 左心室補助装置を移植した患者の肺高血圧症を治療する方法 - Google Patents

左心室補助装置を移植した患者の肺高血圧症を治療する方法 Download PDF

Info

Publication number
JP2024507905A
JP2024507905A JP2023551206A JP2023551206A JP2024507905A JP 2024507905 A JP2024507905 A JP 2024507905A JP 2023551206 A JP2023551206 A JP 2023551206A JP 2023551206 A JP2023551206 A JP 2023551206A JP 2024507905 A JP2024507905 A JP 2024507905A
Authority
JP
Japan
Prior art keywords
macitentan
per day
aprocitentan
patient
days
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023551206A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024507905A5 (https=
Inventor
ロッコ マーク
セレジ モナ
ジャオ キャロル
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Actelion Pharmaceuticals Ltd
Original Assignee
Actelion Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actelion Pharmaceuticals Ltd filed Critical Actelion Pharmaceuticals Ltd
Publication of JP2024507905A publication Critical patent/JP2024507905A/ja
Publication of JP2024507905A5 publication Critical patent/JP2024507905A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
    • A61M60/90—Details not provided for in groups A61M60/40, A61M60/50 or A61M60/80
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Mechanical Engineering (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2023551206A 2021-02-26 2022-02-25 左心室補助装置を移植した患者の肺高血圧症を治療する方法 Pending JP2024507905A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163154348P 2021-02-26 2021-02-26
US63/154,348 2021-02-26
PCT/EP2022/054742 WO2022180194A1 (en) 2021-02-26 2022-02-25 Methods for treating pulmonary hypertension in patients with left ventricular assist device implantation

Publications (2)

Publication Number Publication Date
JP2024507905A true JP2024507905A (ja) 2024-02-21
JP2024507905A5 JP2024507905A5 (https=) 2025-03-07

Family

ID=80933151

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023551206A Pending JP2024507905A (ja) 2021-02-26 2022-02-25 左心室補助装置を移植した患者の肺高血圧症を治療する方法

Country Status (6)

Country Link
US (1) US20240299384A1 (https=)
EP (1) EP4297754A1 (https=)
JP (1) JP2024507905A (https=)
CN (1) CN116887835A (https=)
CA (1) CA3208560A1 (https=)
WO (1) WO2022180194A1 (https=)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105693624B (zh) * 2013-06-14 2018-05-18 杭州普晒医药科技有限公司 马西替坦晶体及其制备方法、其药物组合物和用途
PT3897646T (pt) * 2018-12-21 2024-07-08 Actelion Pharmaceuticals Ltd Macitentano para tratamento de hipertensão arterial pulmonar

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
J ARTIF ORGANS, vol. 16, JPN6026005697, 2013, pages 101 - 104, ISSN: 0005797051 *
JOURNAL OF CARDIAC FAILURE, vol. Vol.22, No.8S, JPN6026005696, 2016, pages 14 - 033, ISSN: 0005797050 *
PULMONARY CIRCULATION, vol. 8, no. 3, JPN6026005699, 2018, pages 1 - 5, ISSN: 0005797049 *

Also Published As

Publication number Publication date
CN116887835A (zh) 2023-10-13
WO2022180194A1 (en) 2022-09-01
US20240299384A1 (en) 2024-09-12
EP4297754A1 (en) 2024-01-03
CA3208560A1 (en) 2022-09-01

Similar Documents

Publication Publication Date Title
JP7620758B2 (ja) 肺動脈性肺高血圧症の治療方法
US20220257595A1 (en) Macitentan for use in treating portopulmonary hypertension
JP2026505367A (ja) 高タンパク尿慢性腎疾患の治療のためのジボテンタン及びダパグリフロジンの合剤
US20250205235A1 (en) Dose regimen for vericiguat
JP2024507905A (ja) 左心室補助装置を移植した患者の肺高血圧症を治療する方法
WO2023062595A1 (en) Treatment of subjects having pulmonary arterial hypertension with rodatristat ethyl
US20250222003A1 (en) Pharmaceutical composition for treating solid tumors
US20240307397A1 (en) Pharmaceutical composition comprising pi3k and dna-pk dual inhibitor for preventing or treating peripheral t cell lymphoma
US20250221970A1 (en) Combinations of a B-RAF Inhibitor and an Anti-EGFR Antibody for the Treatment of Cancer
RU2860237C2 (ru) Способы лечения подагры
WO2024099953A1 (en) Combination of macitentan and tadalafil for the treatment of pulmonary arterial hypertension
HK40110527A (zh) 伊奈利珠单抗及其在治疗或预防igg4相关疾病中的使用方法
TW202535375A (zh) 苯並氮雜芳環衍生物在治療補體因數b介導的疾病中的用途
CN117940161A (zh) 伊奈利珠单抗及其在治疗或预防IgG4相关疾病中的使用方法
US20230381190A1 (en) Methods and Treatment for Complex Lymphatic Malformations
WO2023059714A1 (en) Methods of treating estrogen receptor-mediated disorders
KR20250095627A (ko) 에스트로겐 수용체-매개 장애의 치료 방법

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250225

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250225

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20260121

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20260217